|
A Study of Patients Who Recently Have Been Infected with HIV Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on A Study of Patients Who Recently Have Been Infected with HIV conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A Study of Patients Who Recently Have Been Infected with HIV Clinical research trials and A Study of Patients Who Recently Have Been Infected with HIV healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like A Study of Patients Who Recently Have Been Infected with HIV. A Study of Patients Who Recently Have Been Infected with HIV Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A Study of Patients Who Recently Have Been Infected with HIV clinical trial. Human subjects often obtain the finest healthcare possible for their A Study of Patients Who Recently Have Been Infected with HIV condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Study of Patients Who Recently Have Been Infected with HIV  A Study of Patients Who Recently Have Been Infected with HIV
A Study of Patients Who Recently Have Been Infected with HIV
For Condition: HIV Infections
Status: Recruiting
Sponsor(s): National Institute of Allergy and Infectious Diseases (NIAID) ,
Synopsis: The purpose of this study is to find out if anti-HIV drugs, taken by patients who are newly infected with HIV, can make the level of HIV in the body too low to detect. Studying patients who recently have been infected with HIV may help researchers understand how HIV infection works and how anti-HIV drugs may help these patients. Approved anti-HIV drugs can reduce the amount of HIV, but more research needs to be done in newly infected patients. This study will look at recently HIV-infected patients to study the progression of HIV disease and to see whether anti-HIV drugs can reduce the level of HIV.
Details: Primary and early HIV infection represents a potentially unique opportunity to better understand the pathogenesis of HIV infection, as well as to potentially prevent the establishment of latent infection. Approved antiretroviral therapy is able to reduce plasma viremia to unmeasurable levels in established infection and several groups have observed comparable effects in recently infected adults. This study is designed to evaluate and follow a cohort of patients with primary or early HIV infection and to evaluate the time course of latent infection and whether latent infection in CD4 cells will allow viral persistence despite antiretroviral therapy. Patients begin antiretroviral therapy within 7 days of enrollment. All patients are evaluated for treatment compliance and complete a compliance questionnaire regularly. Clinical evaluations, including CD4, CD8, and HIV RNA counts also are done regularly. Antiretroviral therapy is discontinued if there is no detectable virus by ultrasensitive assay and culture techniques in plasma, PBMCs, and lymphoid tissue. In a subset of patients, genital secretions and CSF (cerebrospinal fluid) are evaluated. If relapse occurs, antiretroviral therapy is re-instituted. In addition, virology and immunology substudies are performed.
Eligibility:
Study Type: Observational, Natural History
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: Inclusion Criteria Patients may be eligible for this study if they: - Have had certain tests indicating that they recently have been infected with HIV. - Agree to use effective methods of birth control during the study and for 3 months after. - Are at least 18 years old. Exclusion Criteria Patients will not be eligible for this study if they: - Have taken anti-HIV drugs. - Take erythropoietin, G-CSF or GM-CSF within 30 days of study entry. - Take interferons, interleukins, cytotoxic chemotherapy, or HIV vaccines within 30 days of study entry. - Take medications that should not be taken with their prescribed anti-HIV drugs. - Have had radiation treatment within 30 days of study entry. - Are pregnant or breast-feeding.
Total Enrollment: 60
Location and Contact Information:
Overall Study Official:
MargaretFischl, Study Chair,
Unspecified *Recruiting*
Horsham, Pennsylvania, 19044
United States
Recruiting
Additional Information:
Study ID Numbers: AIEDRP AI-08-004; ACRU 010
Study Start Date:
Record last reviewed: December 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00006415
Other Hiv Infections Studies:
1. A Phase I Trial of HIV-1 C4-V3 Polyvalent Peptide Vaccine in HIV-1 Infected Persons
2. T-20 with Anti-HIV Combination Therapy for Patients with Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs
3. The Antiviral Efficacy of Concurrent Zidovudine and 2',3'-dideoxyinosine or 2',3'-dideoxycytidine in Patients with Human Immunodeficiency Virus Disease
4. An Evaluation of Pentoxifylline in HIV-Positive Persons With Symptomatic HIV Infection and a Karnofsky Score > 40 Percent and < 100 Percent
5. A Randomized, Double-Blind Study of the Efficacy and Safety of Oral Ganciclovir for the Prevention of CMV Disease in People Infected With the Human Immunodeficiency Virus
Related Studies:
Other HIV Infections Clinical Trials
Other Pennsylvania Clinical Trials
Other Horsham Clinical Trials
A Study of Patients Who Recently Have Been Infected with HIV
|
|
|
|
|
|
|
|
